Obseva SA banner
O

Obseva SA
SIX:OBSN

Watchlist Manager
Obseva SA
SIX:OBSN
Watchlist
Price: 0.0012 CHF -76.92% Market Closed
Market Cap: CHf140.6k

During the last 3 months Obseva SA insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Apr 5, 2023 by Non-Executive Director , who bought 344k CHF worth of OBSN shares.

Last Transactions:
Non-Executive Director
CHf+344k
Non-Executive Director
CHf-233.5k
Non-Executive Director
CHf+2.1k
Non-Executive Director
CHf+64.2k
Non-Executive Director
CHf+70.7k
Non-Executive Director
CHf+69.7k
Non-Executive Director
CHf+177.6k
Executive Board Member/ Officer
CHf+1.4m
Executive Board Member/ Officer
CHf+187.1k
Executive Board Member/ Officer
CHf+183.4k
Executive Board Member/ Officer
CHf+158.9k
Executive Board Member/ Officer
CHf+148k
Executive Board Member/ Officer
CHf+60.8k
Executive Board Member/ Officer
CHf+49.6k
View All Transactions

During the last 3 months Obseva SA insiders have not bought any shares, and have not sold any shares.

The last transaction was made on Apr 5, 2023 by Non-Executive Director , who bought 344k CHF worth of OBSN shares.

Sold
0-3
months
0 CHF
0
3-6
months
0 CHF
0
6-9
months
0 CHF
0
9-12
months
0 CHF
0
Bought
0-3
months
No Insider Transactions
0
0 CHF
3-6
months
No Insider Transactions
0
0 CHF
6-9
months
No Insider Transactions
0
0 CHF
9-12
months
No Insider Transactions
0
0 CHF

Obseva SA
Insider Trading Chart

Obseva SA
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Obseva SA
Last Insider Transactions

Global
Insiders Monitor

Obseva SA
Glance View

Market Cap
140.6k CHF
Industry
Biotechnology

ObsEva SA is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. The company is headquartered in Plan-Les-Ouates, Geneve and currently employs 51 full-time employees. The company went IPO on 2018-07-13. The firm develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban (OBE001), an oral oxytocin receptor antagonist undergoing phase 3 of clinical trials, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor (phase 2a of clinical trials).

OBSN Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett